Read More 16 minute read Options Stocks That Hit 52-Week Lows On Wednesday By Benzinga Insights Today, 3:14 AM On Wednesday, 258 companies hit new 52-week lows. ACB
Read More 17 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 3:14 AM During Friday's trading, 293 companies set new 52-week lows. ACEL
Read More 9 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 3:14 AM On Friday, 127 companies set new 52-week lows. $APE
Read More 5 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 3:14 AM On Friday, 72 companies hit new 52-week lows. AIP
Read More 1 minute read Analyst Ratings Downgrades News HC Wainwright & Co. Downgrades SQZ Biotechnologies to Neutral By Benzinga Newsdesk Today, 3:14 AM HC Wainwright & Co. analyst Emily Bodnar downgrades SQZ Biotechnologies (NYSE:SQZ) from Buy to Neutral. SQZ
Read More 4 minute read Intraday Update Markets Movers News Penny Stocks Small Cap Trading Ideas Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday’s Mid-Day Session By Lisa Levin Today, 3:14 AM Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250. AHI
Read More 3 minute read Commodities Earnings Eurozone Global Intraday Update Markets News Penny Stocks Small Cap US Stocks Mixed After Wednesday’s Rally By Lisa Levin Today, 3:14 AM U.S. stocks traded mixed this morning, with the Dow Jones falling around 180 points on Thursday. ARCE
Read More 15 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For December 1, 2022 By Benzinga Insights Today, 3:14 AM Upgrades Northcoast Research upgraded the previous rating for SpartanNash Co (NASDAQ:SPTN) from Neutral to Buy. SpartanNash earned $0.55… ACRS
Read More 1 minute read Analyst Ratings Downgrades News Price Target B of A Securities Downgrades SQZ Biotechnologies to Underperform, Lowers Price Target to $2 By Benzinga Newsdesk Today, 3:14 AM B of A Securities analyst Tazeen Ahmad downgrades SQZ Biotechnologies (NYSE:SQZ) from Buy to Underperform and lowers the price target from $9 to $2. SQZ
Read More 1 minute read Analyst Color Analyst Ratings Biotech General Health Care Initiation Movers News Penny Stocks Price Target Trading Ideas Analyst Bullish On SQZ Biotech’s Technology For Solving Cell Therapy Challenges By Vandana Singh Today, 3:14 AM HC Wainwright initiated coverage on SQZ Biotechnologies Company (NYSE:SQZ) with a Buy rating and a price target of $10. SQZ is focused… RHHBY